Novartis AG
COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO TIM-3
Last updated:
Abstract:
Combination therapies comprising antibody molecules that specifically bind to TIM-3 are disclosed. The combination therapies can be used to treat or prevent cancerous or infectious conditions and disorders.
Status:
Application
Type:
Utility
Filling date:
17 Sep 2021
Issue date:
5 May 2022